Curated News
By: NewsRamp Editorial Staff
August 10, 2026
Voyageur Advances Iodine Extraction with 99.8% Purity, Field Pilot Next
TLDR
- Voyageur's 99.8% pure iodine extraction from oilfield brine gives early mover advantage in the North American contrast media market.
- The Mueller process recovers high-purity iodine from oilfield brine via continuous lab pilot, achieving over 90% recovery and clean brine output.
- Turning waste brine into medical iodine reduces environmental disposal costs and secures domestic supply for life-saving imaging agents.
- Iodine from oilfield brine, once a waste product, could soon be used in your next CT scan, thanks to this new tech.
Impact - Why it Matters
This news matters because it signals a potential shift in the medical imaging supply chain. Currently, North America relies heavily on imported iodine for contrast media, leaving the market vulnerable to price volatility and supply disruptions. Voyageur's success in extracting high-purity iodine from oilfield brine could establish a domestic, cost-effective source, reducing dependency on foreign suppliers. For oil and gas producers, it turns a waste product into a revenue stream, promoting environmental sustainability through brine valorization. If the field pilot proves successful, it could pave the way for a new industry standard, impacting everything from healthcare costs to energy sector economics.
Summary
Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF), a Canadian developer of pharmaceutical-grade barium and iodine contrast media, has announced significant progress in its proprietary Mueller iodine extraction process. The company reported that recent laboratory work has successfully produced iodine at 99.8% purity with an overall recovery exceeding 90%, using iodine-rich oilfield brine. This achievement is a key step in Voyageur's strategy to establish a domestic iodine supply for the North American radiology contrast media market, while also providing oil and gas producers and midstream water operators a new avenue to generate value from produced brine.
The company has established a laboratory and fabrication site in Houston, Texas, to advance the Mueller process using Anadarko and Permian Basin produced water. Laboratory operations have validated the process under controlled conditions, generating clean brine suitable for disposal or reinjection, consistent with zero-liquid-discharge objectives. A field-capable pilot unit, sized to 80,000 liters per day, has been constructed and is scheduled to commence field testing in September 2026. This transition from bench-scale to real-world field operation is considered critical for commercial deployment.
Engineering and scale-up planning are progressing, with a preliminary design basis for a 200 metric ton per year plant completed, along with techno-economic and environmental validation supporting low-cost OPEX. Voyageur's modular production concept allows for relocatable units at multiple saltwater disposal sites, with iodine concentrate transported to a central hub for final processing. The company plans to develop up to 1,000 tonnes per year of iodine capacity to support its future contrast pharmaceutical production. Brent Willis, President and CEO, emphasized that achieving high purity and recovery provides meaningful technical validation as they prepare for field operations.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Voyageur Advances Iodine Extraction with 99.8% Purity, Field Pilot Next
